Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

AnGes Inc

4563
Current price
49 JPY -0.99 JPY (-2.00%)
Last closed 50 JPY
ISIN JP3127700007
Sector Healthcare
Industry Biotechnology
Exchange Tokyo Stock Exchange
Capitalization 11 727 747 173 JPY
Yield for 12 month -48.96 %
1Y
3Y
5Y
10Y
15Y
4563
21.11.2021 - 28.11.2021

AnGes, Inc., a biopharmaceutical company, engages in the research and development of gene-based medical products. Its lead product is Hepatocyte Growth Factor (HGF) Plasmid, a gene therapy for the treatment of ischemic diseases. The company is also developing NF-kB Decoy Oligonucleotide, a nucleic acid medicine that suppresses inflammation for diseases, including low back pain; drugs for treating atopic dermatitis and asthma; medical devices for the prevention of vascular medicine; cervical intraepithelial neoplasia therapeutic vaccines for cervical cancer; and DNA vaccines for high blood pressure through collaborative research agreement with Osaka University. The company was formerly known as AnGes MG, Inc. and changed its name to AnGes, Inc. in July 2017. AnGes, Inc. was incorporated in 1999 and is headquartered in Ibaraki, Japan. Address: Saito Bio-Incubator, Ibaraki, Japan, 567-0085

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

86 944.91 JPY

P/E ratio

Dividend Yield

Current Year

+152 331 831 JPY

Last Year

+66 774 673 JPY

Current Quarter

+233 015 867 JPY

Last Quarter

+113 076 204 JPY

Current Year

-3 052 200 256 JPY

Last Year

-2 907 809 300 JPY

Current Quarter

-775 374 435 JPY

Last Quarter

-739 112 938 JPY

Key Figures 4563

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -7 782 630 815 JPY
Operating Margin TTM -1124.36 %
PE Ratio
Return On Assets TTM -21.57 %
PEG Ratio
Return On Equity TTM -22.89 %
Wall Street Target Price 86 944.91 JPY
Revenue TTM 446 087 335 JPY
Book Value 106.87 JPY
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 568.6 %
Dividend Yield
Gross Profit TTM -26 884 728 JPY
Earnings per share -29.67 JPY
Diluted Eps TTM -29.67 JPY
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics 4563

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 4563

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 100:1
Payout Ratio
Last Split Date 26.12.2013
Dividend Date

Stock Valuation 4563

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 22.907
Price Sales TTM 26.2902
Enterprise Value EBITDA -0.762
Price Book MRQ 0.4623

Financials 4563

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 4563

For 52 weeks

42.82 JPY 97.58 JPY
50 Day MA 57.04 JPY
Shares Short Prior Month
200 Day MA 61.11 JPY
Short Ratio
Shares Short
Short Percent